Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.

Source:http://linkedlifedata.com/resource/pubmed/id/3625258

Download in:

View as

General Info

PMID
3625258